|
Mamatkulov B.B., Mamatkulov I.B.
Diagnostic value of echocardiography parameters for assessing intravascular status in nephrotic syndrome in children
|
№4 / 2023
|
|
Murkamilov I.T., Fomin V.V., Sabirov I.S., Satkynalieva Z.T., Yusupov F.A.
Thrombosis and embolism in patients with chronic kidney disease
|
№2 / 2023
|
|
E.V. Voloshinova, N.M. Nikitina, N. D. Smirnova, E.V. Egorova
Features of the course of aa-amyloidosis in rheumatoid arthritis against the background of COVID-19 infection
|
№2 / 2021
|
|
I.T. Murkamilov, I.S. Sabirov, V.V. Fomin, ZH.A. Murkamilova, K.A. Aytbaev
Membranous glomerulonephritis: a modern view of the problem and treatment options
|
№1 / 2020
|
|
N.V. Chebotareva, N.V. Neprintseva, I.N. Bobkova, L.V. Kozlovskaya, V.A. Varshavsky.
Definition of heat shock proteins in the urine, serum and kidney tissue: significance for the assessment of activity and prognosis of chronic glomerulonephritis
|
№5 / 2014
|
|
A.A. Pulin, T.Yu. Kustova, M.Yu. Brovko, L.V. Lysenko, V.V. Fomin, N.A. Muhin
Clinical assessment of circulating (pro-ANP) and renal interstitial (CGMP) natriuretic peptides in proteinuric forms of chronic glomerulonephritis
|
№4 / 2014
|
|
S.S. Girina, A.A. Pulin, V.Yu. Kornienko, V.G. Pinelis, A.N. Tcygin, A.Yu. Asanov, L.V. Kozlovskaya, V.V. Fomin, N.A. Mukhin
Role of podocin gene mutations in assessment of resistance of proteinuric nephritis to standard immunosupressive therapy
|
№4 / 2014
|
|
V.V. Skvortsov, A.V. Tumarenko, E.M. Skvortsova, N.A. Ellenberger
Nephrotic syndrome: diagnosis and treatment
|
№1 / 2013
|
|
S.S. Girina, V.V. Fomin, A.A. Pulin, N.A. Mukhin
Polymorphism of podocyte protein genes in nephrotic glomerulonephritis, resistant to standard regimens of immunosupressive therapy
|
№1 / 2012
|
|
N.L. Kozlovskaya, L.A. Bobrova
Renal vein thrombosis
|
№1 / 2012
|
|
Kulina E.V.
Role of omega-3 unsaturated fatty acids in treatment of progressive kidney diseases
|
№6 / 2011
|
|
A.A. Pulin, E.Yu.Gornostaeva, S.V. Roschupkina, S.S. Gririna, L.V. Kozlovskaya
Succesful rituximab therapy of membranous nephropathy, resistant to standard immunosupressive treatment
|
№5 / 2011
|
Русский
